- Insights This article was written by a TIA community member. Insights pieces undergo the same rigorous editorial process that newsroom-produced articles have.
AI mega-rounds put corporate investors in the driver’s seat
In September 2025, Dutch semiconductor equipment maker ASML invested 1.3 billion euros (US$1.4 billion) in French AI startup Mistral, establishing a partnership to explore applications of its technology. Amazon, Nvidia, and SoftBank anchored OpenAI’s US$122 billion round this year, while Japan’s SBI Holdings invested US$270 million for a 20% stake in Indonesian investment platform Ajaib.
Corporate investors are playing a bigger role in venture financing. Some invest directly from their balance sheets, while others use dedicated corporate venture capital (CVC) funds.

Image credit: Timmy Loen and Ulla
Their motivations can be strategic, financial, or a combination of both. But how much of this activity will last beyond today’s AI mega-rounds?
A bigger footprint in the largest rounds
Corporate investors have participated in around 20% of global venture deals in the past decade. Over that period, the size of the rounds they join has changed.
The 2026 State of CVC report estimates that corporate investors participated in about 21% of venture deals in 2026, but those rounds accounted for 73% of total venture funding value, compared with 46% to 56% between 2015 and 2025. Those figures consider the full value of rounds involving corporates, not the amount that corporations invested themselves.
This year’s figures use data through August and are heavily influenced by AI mega-rounds, referring to those raising at least US$100 million in funding.
The report projects roughly 8,400 corporate-backed deals in 2026, a nine-year low, even as their combined value heads toward a record high. The median of these deals rose from US$7 million in 2021 to US$13 million this year.
Dedicated CVC funds operate on a different scale: their median check is about US$3 million, and the report estimates they account for around 4% of total venture funding.
The stage mix is also shifting. Later-stage (post-series B) deals account for 48% of corporate-backed investments in 2026, up from 32% in 2015, while the share of early-stage (series A and B) deals declined from 47% to 33% over the same period.
Yet 74% of 193 CVC firms surveyed by the report said they preferred investing in series A and B rounds.
These figures suggest that corporate participation extends beyond dedicated CVC funds. Direct balance-sheet investments may be contributing to the larger, later-stage rounds.




